| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Sarena Francis Willard | Chief Strategy Officer | Apr 16, 2021 | Option Exercise | $38.00 | 169,468 | 6,439,784 | 0 | Apr 19, 2021, 08:04 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Sarena Francis Willard | Chief Strategy Officer | Apr 16, 2021 | Option Exercise | $38.00 | 1,590 | 60,420 | 0 | Apr 19, 2021, 08:04 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Sarena Francis Willard | Chief Strategy Officer | Apr 16, 2021 | Option Exercise | $38.00 | 795 | 30,210 | 0 | Apr 19, 2021, 08:04 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Smith David V | Executive Vice President & CFO | Apr 16, 2021 | Option Exercise | $38.00 | 138,947 | 5,279,986 | 0 | Apr 19, 2021, 07:57 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | White David | See Remarks | Apr 16, 2021 | Option Exercise | $38.00 | 33,423 | 1,270,074 | 0 | Apr 19, 2021, 07:49 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | BERGER FRANKLIN M | Director | Apr 16, 2021 | Option Exercise | $38.00 | 5,000 | 190,000 | 0 | Apr 19, 2021, 07:42 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Civik Thomas | President and CEO | Apr 16, 2021 | Option Exercise | $38.00 | 68,971 | 2,620,898 | 0 | Apr 19, 2021, 07:21 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Civik Thomas | President and CEO | Apr 09, 2021 | Option Exercise | $37.94 | 11,088 | 420,679 | 68,971 | Apr 13, 2021, 01:05 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Sarena Francis Willard | Chief Strategy Officer | Feb 26, 2021 | Option Exercise | $22.23 | 1,158 | 25,742 | 123,433 | Mar 02, 2021, 12:16 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Collins Helen Louise | EVP and Chief Medical Officer | Feb 26, 2021 | Option Exercise | $22.23 | 1,158 | 25,742 | 77,632 | Mar 02, 2021, 12:08 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | White David | See Remarks | Feb 28, 2021 | Option Exercise | $22.23 | 1,461 | 32,478 | 33,423 | Mar 02, 2021, 12:00 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Sarena Francis Willard | Chief Strategy Officer | Feb 24, 2021 | Option Exercise | $25.71 | 5,100 | 131,121 | 126,244 | Feb 26, 2021, 02:42 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Sarena Francis Willard | Chief Strategy Officer | Feb 25, 2021 | Option Exercise | $23.08 | 1,653 | 38,151 | 124,591 | Feb 26, 2021, 02:42 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Collins Helen Louise | EVP and Chief Medical Officer | Feb 25, 2021 | Option Exercise | $23.08 | 1,653 | 38,151 | 78,790 | Feb 26, 2021, 02:36 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Collins Helen Louise | EVP and Chief Medical Officer | Feb 24, 2021 | Option Exercise | $25.71 | 5,091 | 130,890 | 80,443 | Feb 26, 2021, 02:36 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Smith David V | Executive Vice President & CFO | Feb 24, 2021 | Option Exercise | $25.71 | 5,110 | 131,378 | 72,947 | Feb 26, 2021, 02:31 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | White David | See Remarks | Feb 24, 2021 | Option Exercise | $25.71 | 1,155 | 29,695 | 34,884 | Feb 26, 2021, 02:26 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Sarena Francis Willard | Chief Strategy Officer | Dec 11, 2020 | Option Exercise | $16.14 | 11,583 | 186,950 | 126,427 | Dec 15, 2020, 12:19 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Smith David V | Executive Vice President & CFO | Dec 11, 2020 | Option Exercise | $16.14 | 11,504 | 185,675 | 78,057 | Dec 15, 2020, 12:09 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Collins Helen Louise | EVP and Chief Medical Officer | Dec 11, 2020 | Option Exercise | $16.14 | 11,583 | 186,950 | 85,534 | Dec 15, 2020, 12:00 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Smith David V | Executive Vice President & CFO | Nov 26, 2020 | Option Exercise | $18.45 | 6,920 | 127,674 | 67,561 | Nov 30, 2020, 02:49 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | BIOTECHNOLOGY VALUE FUND L P | See Explanation of Responses | Nov 11, 2020 | Sale | $20.19 | 7,393,340 | 149,247,143 | 670,695 | Nov 13, 2020, 05:29 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Sarena Francis Willard | Chief Strategy Officer | Nov 11, 2020 | Option Exercise | $18.00 | 11,001 | 198,018 | 116,010 | Nov 13, 2020, 12:38 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Smith David V | Executive Vice President & CFO | Nov 11, 2020 | Option Exercise | $18.00 | 10,908 | 196,344 | 74,481 | Nov 13, 2020, 12:29 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Collins Helen Louise | EVP and Chief Medical Officer | Nov 11, 2020 | Option Exercise | $18.00 | 11,039 | 198,702 | 75,117 | Nov 13, 2020, 12:25 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | RINGO WILLIAM R | Director | Nov 11, 2020 | Option Exercise | $12.46 | 157,918 | 1,966,946 | 62,959 | Nov 13, 2020, 12:17 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | BVF PARTNERS L P/IL | 10% Owner | Nov 04, 2020 | Buy | $4.88 | 416,562 | 2,034,572 | 4,594,679 | Nov 06, 2020, 06:30 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | BVF I GP LLC | 10% Owner | Nov 06, 2020 | Buy | $4.98 | 30,000 | 149,520 | 4,611,909 | Nov 06, 2020, 06:30 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | BVF II GP LLC | See Explanation of Responses | Oct 06, 2020 | Buy | $5.03 | 345,241 | 1,738,288 | 4,336,875 | Oct 08, 2020, 05:27 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | White David | See Remarks | Sep 30, 2020 | Option Exercise | $4.70 | 6,916 | 32,505 | 36,039 | Oct 02, 2020, 01:51 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | BVF INC/IL | 10% Owner | Sep 22, 2020 | Buy | $3.80 | 32 | 122 | 541,116 | Sep 24, 2020, 07:49 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Collins Helen Louise | EVP and Chief Medical Officer | Aug 20, 2020 | Option Exercise | $4.69 | 827 | 3,879 | 64,156 | Aug 24, 2020, 01:46 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | BVF PARTNERS L P/IL | 10% Owner | May 14, 2020 | Buy | $4.10 | 293,587 | 1,203,707 | 4,179,093 | May 18, 2020, 08:02 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Collins Helen Louise | EVP and Chief Medical Officer | Mar 20, 2020 | Option Exercise | $2.30 | 827 | 1,902 | 64,983 | Mar 23, 2020, 12:11 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | White David | See Remarks | Feb 28, 2020 | Option Exercise | $3.83 | 2,045 | 7,832 | 42,955 | Mar 03, 2020, 08:35 AM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Sarena Francis Willard | Chief Strategy Officer | Feb 26, 2020 | Option Exercise | $4.83 | 1,304 | 6,298 | 105,011 | Feb 26, 2020, 08:29 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Sarena Francis Willard | Chief Strategy Officer | Feb 25, 2020 | Option Exercise | $4.87 | 1,863 | 9,073 | 106,315 | Feb 26, 2020, 08:29 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Collins Helen Louise | EVP and Chief Medical Officer | Feb 25, 2020 | Option Exercise | $4.87 | 1,862 | 9,068 | 67,091 | Feb 26, 2020, 08:22 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Collins Helen Louise | EVP and Chief Medical Officer | Feb 26, 2020 | Option Exercise | $4.83 | 1,281 | 6,187 | 65,810 | Feb 26, 2020, 08:22 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Collins Helen Louise | EVP and Chief Medical Officer | Feb 05, 2020 | Option Exercise | $5.13 | 5,345 | 27,420 | 38,953 | Feb 06, 2020, 06:51 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Sarena Francis Willard | Chief Strategy Officer | Feb 05, 2020 | Option Exercise | $5.13 | 4,070 | 20,879 | 78,178 | Feb 06, 2020, 06:49 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Biotechnology Value Trading Fund OS LP | See Explanation of Responses | Dec 20, 2019 | Buy | $4.05 | 515,020 | 2,085,831 | 3,929,792 | Dec 26, 2019, 05:59 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | BIOTECHNOLOGY VALUE FUND II LP | See Explanation of Responses | Dec 09, 2019 | Buy | $4.02 | 135,000 | 542,362 | 3,648,474 | Dec 11, 2019, 06:13 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | BERGER FRANKLIN M | Director | Dec 02, 2019 | Sale | $3.92 | 32,090 | 125,793 | 52,890 | Dec 04, 2019, 06:28 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | BERGER FRANKLIN M | Director | Dec 03, 2019 | Sale | $4.00 | 47,890 | 191,560 | 5,000 | Dec 04, 2019, 06:28 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Smith David V | Executive Vice President & CFO | Nov 26, 2019 | Option Exercise | $3.77 | 6,611 | 24,923 | 33,389 | Nov 27, 2019, 03:53 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | BVF INC/IL | 10% Owner | Nov 22, 2019 | Buy | $3.40 | 1,120,010 | 3,808,146 | 3,534,600 | Nov 26, 2019, 05:59 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | BVF Partners OS Ltd. | See Explanation of Responses | Nov 05, 2019 | Buy | $4.00 | 968,112 | 3,872,448 | 2,958,503 | Nov 07, 2019, 07:22 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | LAMPERT MARK N | 10% Owner | Oct 29, 2019 | Buy | $3.90 | 2,400 | 9,353 | 2,447,977 | Oct 31, 2019, 06:24 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Biotechnology Value Trading Fund OS LP | See Explanation of Responses | Oct 30, 2019 | Buy | $3.89 | 20,081 | 78,157 | 2,458,366 | Oct 31, 2019, 06:24 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | BIOTECHNOLOGY VALUE FUND L P | See Explanation of Responses | Oct 31, 2019 | Buy | $3.85 | 6,833 | 26,304 | 2,461,782 | Oct 31, 2019, 06:24 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | LAMPERT MARK N | 10% Owner | Oct 25, 2019 | Buy | $3.75 | 30,782 | 115,349 | 2,446,950 | Oct 25, 2019, 05:43 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | BIOTECHNOLOGY VALUE FUND II LP | See Explanation of Responses | Oct 23, 2019 | Buy | $3.75 | 3,200 | 11,986 | 2,355,186 | Oct 25, 2019, 05:43 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | BVF INC/IL | 10% Owner | Oct 24, 2019 | Buy | $3.74 | 135,388 | 506,987 | 2,431,222 | Oct 25, 2019, 05:43 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Biotechnology Value Trading Fund OS LP | See Explanation of Responses | Oct 07, 2019 | Buy | $3.75 | 525,070 | 1,968,664 | 2,320,979 | Oct 08, 2019, 05:40 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | BVF Partners OS Ltd. | See Explanation of Responses | Oct 08, 2019 | Buy | $3.68 | 60,412 | 222,497 | 2,351,986 | Oct 08, 2019, 05:40 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | BVF PARTNERS L P/IL | 10% Owner | Oct 04, 2019 | Buy | $3.74 | 16,000 | 59,800 | 2,054,006 | Oct 08, 2019, 05:40 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Williams Lewis T | Director | Sep 01, 2019 | Option Exercise | $5.43 | 7,024 | 38,140 | 455,336 | Sep 04, 2019, 01:20 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Knickerbocker Aron Marc | President & CEO | Sep 01, 2019 | Option Exercise | $5.43 | 3,306 | 17,952 | 42,057 | Sep 04, 2019, 01:18 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Sarena Francis Willard | Chief Strategy Officer | Sep 01, 2019 | Option Exercise | $5.43 | 2,811 | 15,264 | 82,248 | Sep 04, 2019, 01:15 PM | |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Collins Helen Louise | EVP and Chief Medical Officer | Sep 01, 2019 | Option Exercise | $5.43 | 496 | 2,693 | 44,298 | Sep 04, 2019, 01:12 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Knickerbocker Aron Marc | President & CEO | Jun 07, 2019 | Option Exercise | $5.54 | 11,357 | 62,918 | 195,828 | Jun 10, 2019, 01:53 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Irving Bryan | EVP, Chief Scientific Officer | May 15, 2019 | Option Exercise | $9.17 | 620 | 5,685 | 30,533 | May 16, 2019, 06:29 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Knickerbocker Aron Marc | President & CEO | Feb 26, 2019 | Option Exercise | $11.95 | 2,462 | 29,421 | 218,445 | Feb 27, 2019, 08:07 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Irving Bryan | EVP, Chief Scientific Officer | Feb 26, 2019 | Option Exercise | $11.95 | 1,118 | 13,360 | 31,153 | Feb 27, 2019, 08:01 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Collins Helen Louise | SVP and Chief Medical Officer | Feb 26, 2019 | Option Exercise | $11.95 | 1,177 | 14,065 | 39,794 | Feb 27, 2019, 07:58 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Sarena Francis Willard | Chief Strategy Officer | Feb 26, 2019 | Option Exercise | $11.95 | 1,194 | 14,268 | 82,955 | Feb 27, 2019, 07:53 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Williams Lewis T | Director | Feb 26, 2019 | Option Exercise | $11.95 | 926 | 11,066 | 461,360 | Feb 27, 2019, 07:49 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Sarena Francis Willard | Chief Strategy Officer | Feb 05, 2019 | Option Exercise | $11.43 | 2,996 | 34,244 | 74,149 | Feb 07, 2019, 05:24 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Collins Helen Louise | SVP and Chief Medical Officer | Feb 05, 2019 | Option Exercise | $11.43 | 3,196 | 36,530 | 30,971 | Feb 07, 2019, 05:21 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Williams Lewis T | Director | Feb 05, 2019 | Option Exercise | $11.43 | 3,144 | 35,936 | 462,286 | Feb 07, 2019, 05:18 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Knickerbocker Aron Marc | President & CEO | Feb 05, 2019 | Option Exercise | $11.43 | 2,996 | 34,244 | 195,063 | Feb 07, 2019, 05:14 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Williams Lewis T | Executive Chairman | Nov 05, 2018 | Option Exercise | $4.56 | 91,217 | 415,950 | 465,430 | Nov 13, 2018, 08:32 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Knickerbocker Aron Marc | President & CEO | Sep 28, 2018 | Option Exercise | $13.92 | 954 | 13,280 | 196,966 | Oct 02, 2018, 06:50 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Sarena Francis Willard | Chief Strategy Officer | Sep 28, 2018 | Option Exercise | $13.92 | 954 | 13,280 | 77,145 | Oct 02, 2018, 06:46 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Collins Helen Louise | SVP and Chief Medical Officer | Sep 28, 2018 | Option Exercise | $13.92 | 1,906 | 26,532 | 34,167 | Oct 02, 2018, 06:43 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Knickerbocker Aron Marc | President & CEO | Sep 26, 2018 | Option Exercise | $11.14 | 584 | 6,506 | 196,145 | Sep 27, 2018, 12:12 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Knickerbocker Aron Marc | President & CEO | Sep 24, 2018 | Option Exercise | $11.14 | 500 | 5,570 | 195,561 | Sep 25, 2018, 12:58 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Knickerbocker Aron Marc | President & CEO | Sep 19, 2018 | Option Exercise | $11.14 | 500 | 5,570 | 195,061 | Sep 20, 2018, 12:29 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Knickerbocker Aron Marc | President & CEO | Sep 17, 2018 | Option Exercise | $11.14 | 500 | 5,570 | 194,561 | Sep 18, 2018, 12:57 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Knickerbocker Aron Marc | President & CEO | Sep 12, 2018 | Option Exercise | $11.14 | 1,000 | 11,140 | 194,061 | Sep 12, 2018, 12:00 AM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Knickerbocker Aron Marc | President & CEO | Sep 05, 2018 | Option Exercise | $11.14 | 500 | 5,570 | 193,061 | Sep 06, 2018, 01:45 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Knickerbocker Aron Marc | President & CEO | Sep 04, 2018 | Option Exercise | $11.14 | 500 | 5,570 | 192,561 | Sep 05, 2018, 01:05 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Knickerbocker Aron Marc | President & CEO | Sep 01, 2018 | Option Exercise | $14.00 | 3,306 | 46,284 | 192,061 | Sep 05, 2018, 01:03 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Williams Lewis T | Executive Chairman | Sep 01, 2018 | Option Exercise | $14.00 | 7,024 | 98,336 | 374,213 | Sep 05, 2018, 01:00 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Sarena Francis Willard | Chief Strategy Officer | Sep 01, 2018 | Option Exercise | $14.00 | 2,810 | 39,340 | 76,177 | Sep 05, 2018, 11:27 AM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Irving Bryan | EVP, Chief Scientific Officer | Sep 01, 2018 | Option Exercise | $14.00 | 2,479 | 34,706 | 22,271 | Sep 05, 2018, 11:24 AM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Collins Helen Louise | SVP and Chief Medical Officer | Sep 01, 2018 | Option Exercise | $14.00 | 496 | 6,944 | 32,229 | Sep 05, 2018, 11:22 AM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Knickerbocker Aron Marc | President & CEO | Aug 27, 2018 | Option Exercise | $11.14 | 500 | 5,570 | 195,367 | Aug 28, 2018, 10:06 AM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Knickerbocker Aron Marc | President & CEO | Aug 22, 2018 | Option Exercise | $11.14 | 500 | 5,570 | 194,867 | Aug 23, 2018, 03:33 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Knickerbocker Aron Marc | President & CEO | Aug 21, 2018 | Option Exercise | $11.14 | 500 | 5,570 | 194,367 | Aug 22, 2018, 02:38 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Knickerbocker Aron Marc | President & CEO | Aug 20, 2018 | Option Exercise | $11.14 | 500 | 5,570 | 193,867 | Aug 21, 2018, 12:54 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Knickerbocker Aron Marc | President & CEO | Aug 15, 2018 | Option Exercise | $11.14 | 500 | 5,570 | 193,367 | Aug 16, 2018, 01:18 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Knickerbocker Aron Marc | President & CEO | Aug 13, 2018 | Option Exercise | $11.14 | 500 | 5,570 | 192,867 | Aug 14, 2018, 03:18 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Knickerbocker Aron Marc | President & CEO | Aug 07, 2018 | Option Exercise | $11.14 | 500 | 5,570 | 191,867 | Aug 08, 2018, 07:49 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Knickerbocker Aron Marc | President & CEO | Aug 08, 2018 | Option Exercise | $11.14 | 500 | 5,570 | 192,367 | Aug 08, 2018, 07:49 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Collins Helen Louise | SVP and Chief Medical Officer | Jun 23, 2018 | Option Exercise | $17.38 | 1,240 | 21,551 | 32,725 | Jun 26, 2018, 08:16 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Collins Helen Louise | SVP and Chief Medical Officer | Mar 20, 2018 | Option Exercise | $16.26 | 827 | 13,447 | 33,965 | Mar 22, 2018, 02:50 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Collins Helen Louise | SVP and Chief Medical Officer | Jun 23, 2017 | Option Exercise | $31.24 | 940 | 29,366 | 27,792 | Feb 28, 2018, 07:18 PM | |
| FPRX | FIVE PRIME THERAPEUTICS INC | Williams Lewis T | Executive Chairman | Sep 01, 2016 | Option Exercise | $44.74 | 32,613 | 1,459,106 | 431,715 | Feb 13, 2018, 11:36 AM |
Menu